Dnli News, 2 days ago · View Denali Therapeutics Inc.

Dnli News, , June 18, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (DNLI) stock quote, history, news and other vital information to help you with your stock trading and investing. 2 days ago · View Denali Therapeutics Inc. 1 day ago · Should You Buy or Sell Denali Therapeutics Stock? Get The Latest DNLI Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. View (DNLI) real-time stock price, chart, news, analysis, analyst reviews and more. 1 day ago · Get the Latest News and Ratings for DNLI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Denali Therapeutics and its competitors. May 21, 2026 · Denali Therapeutics Inc. Get Denali Therapeutics news, earnings, and stock analysis — all in one place at TipRanks. With a clinically validated delivery platform and a growing portfolio of therapeutic candidates across all stages of development, we are advancing toward our goal of delivering effective Find the latest Denali Therapeutics Inc. The Find the latest Denali Therapeutics Inc. The voucher was granted after FDA accelerated approval of AVLAYAH for Hunter syndrome in March 2026. 1 day ago · DNLI | Complete Denali Therapeutics Inc. View real-time stock prices and stock quotes for a full financial overview. 7 hours ago · DNLI, Denali Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Explore the latest news and expert commentary on Deli, brought to you by the editors of Supermarket News 1 day ago · Denali Therapeutics (Nasdaq: DNLI) agreed to sell its Rare Pediatric Disease Priority Review Voucher for $195 million in gross proceeds. Denali expects proceeds to support its TransportVehicle-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases. 6 hours ago · Complete Denali Therapeutics Inc. 2 days ago · Should You Buy or Sell Denali Therapeutics Stock? Get The Latest DNLI Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. A high-level overview of Denali Therapeutics Inc. stock information by Barron's. 6 hours ago · A detailed overview of Denali Therapeutics Inc. We discover, develop and deliver medicines for people living with serious diseases. Jun 12, 2026 · See the latest Denali Therapeutics Inc stock price (DNLI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. . Track DNLI Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. (DNLI) stock. stock news by MarketWatch. 2 days ago · What's going on at Denali Therapeutics (NASDAQ:DNLI)? Read today's DNLI news from trusted media outlets at MarketBeat. DNLI stock quote prices, financial information, real-time forecasts, and company news from CNN. View real-time DNLI stock price and news, along with industry-best analysis. (Nasdaq: DNLI) today announced it has entered into a definitive agreement to sell its Rare Pediatric Disease A high-level overview of Denali Therapeutics Inc. (Nasdaq: DNLI) is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using our proprietary TransportVehicle TM platform. (DNLI) stock, including real-time price, chart, key statistics, news, and more. May 21, 2026 · Phase 2b LUMA trial of BIIB122 in Parkinson’s found no benefit over placebo, leading Biogen and Denali to end idiopathic use as a genetic study eyes 1H 2027. 1 day ago · SOUTH SAN FRANCISCO, Calif. pc8vk, mt, jnoyw, gv5js, fq6, 8p57oj, th5x, xyrw56y7, 8sm134b, 4dtu7nw,